Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes.

Few trials of glucose-lowering drugs or strategies in people with type 2 diabetes have investigated cardiovascular outcomes, even though most patients die from cardiovascular causes despite the beneficial effects of lipid-reducing and blood pressure-lowering treatments. The evidence-based reduction...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Holman, R, Sourij, H, Califf, R
التنسيق: Journal article
اللغة:English
منشور في: Lancet 2014